Advanced Materials · 2023 · 358 citations · 25 references
EngineeringBioengineeringBiomedical EngineeringInflammationRegenerative MedicineWound HealingDiabetic Foot Ulcer CareDiabetic Foot UlcerationWound CareWound Healing BiomaterialsWound Healing ResponseWound InflammationDiabetic Foot DisordersDiabetic Wound HealingDiabetic Wound PathophysiologyDiabetic Wound RepairImmunomodulatory BiomaterialsRegenerative HydrogelsWound Dressing HydrogelsWound Healing Hydrogels
Diabetic foot ulcers are a severe, rapidly growing complication driven by hyperglycemia‑induced inflammation and excessive reactive oxygen species that reinforce each other, yet current therapies fail to target both aspects. This study proposes an immunomodulatory hydrogel that self‑cascades glucose depletion and ROS scavenging to regulate the diabetic microenvironment. The AuPt@melanin‑incorporated hydrogel (GHM3) delivers hyperthermia‑enhanced local glucose depletion and ROS scavenging. In vitro, in vivo, and RNA‑seq data show that GHM3 disrupts the ROS‑inflammation cycle, shifts macrophage polarization toward M2, and improves healing of dorsal skin and DFU wounds in diabetic rats, offering a safe, efficient treatment.
Abstract Current therapeutic protocols for diabetic foot ulcers (DFUs), a severe and rapidly growing chronic complication in diabetic patients, remain nonspecific. Hyperglycemia‐caused inflammation and excessive reactive oxygen species (ROS) are common obstacles encountered in DFU wound healing, often leading to impaired recovery. These two effects reinforce each other, forming an endless loop. However, adequate and inclusive methods are still lacking to target these two aspects and break the vicious cycle. This study proposes a novel approach for treating DFU wounds, utilizing an immunomodulatory hydrogel to achieve self‐cascade glucose depletion and ROS scavenging to regulate the diabetic microenvironment. Specifically, AuPt@melanin‐incorporated (GHM3) hydrogel dressing is developed to facilitate efficient hyperthermia‐enhanced local glucose depletion and ROS scavenging. Mechanistically, in vitro/vivo experiments and RNA sequencing analysis demonstrate that GHM3 disrupts the ROS‐inflammation cascade cycle and downregulates the ratio of M1/M2 macrophages, consequently improving the therapeutic outcomes for dorsal skin and DFU wounds in diabetic rats. In conclusion, this proposed approach offers a facile, safe, and highly efficient treatment modality for DFUs.
25
Immunoregulation in Diabetic Wound Repair with a Photoenhanced Glycyrrhizic Acid Hydrogel Scaffold
Yuna Qian, Yujing Zheng, Juan Jin et al. · Advanced Materials · 2022 · 698 citations
Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy
Yufeng Liu, Yuan Cheng, He Zhang et al. · Science Advances · 2020 · 561 citations · Full text
A strain-programmed patch for the healing of diabetic wounds
Georgios Theocharidis, Hyunwoo Yuk, Heejung Roh et al. · Nature Biomedical Engineering · 2022 · 316 citations
Medicine, Bioengineering, Surgery +14